Amplifon SpA (AMFPF)
12.01
0.00 (0.00%)
USD |
OTCM |
Jun 10, 16:00
Amplifon Price to Book Value : 2.130 for June 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 10, 2026 | 2.130 |
| June 09, 2026 | 2.130 |
| June 08, 2026 | 2.130 |
| June 05, 2026 | 2.130 |
| June 04, 2026 | 2.130 |
| June 03, 2026 | 2.130 |
| June 02, 2026 | 2.130 |
| June 01, 2026 | 2.130 |
| May 29, 2026 | 2.130 |
| May 28, 2026 | 2.130 |
| May 27, 2026 | 2.568 |
| May 26, 2026 | 2.568 |
| May 22, 2026 | 2.568 |
| May 21, 2026 | 2.039 |
| May 20, 2026 | 2.236 |
| May 19, 2026 | 2.236 |
| May 18, 2026 | 2.236 |
| May 15, 2026 | 2.236 |
| May 14, 2026 | 2.236 |
| May 13, 2026 | 2.236 |
| May 12, 2026 | 2.236 |
| May 11, 2026 | 2.114 |
| May 08, 2026 | 2.114 |
| May 07, 2026 | 2.114 |
| May 06, 2026 | 2.114 |
| Date | Value |
|---|---|
| May 05, 2026 | 2.114 |
| May 04, 2026 | 1.860 |
| May 01, 2026 | 1.860 |
| April 30, 2026 | 1.860 |
| April 29, 2026 | 1.860 |
| April 28, 2026 | 1.789 |
| April 27, 2026 | 1.789 |
| April 24, 2026 | 1.789 |
| April 23, 2026 | 1.789 |
| April 22, 2026 | 1.789 |
| April 21, 2026 | 1.789 |
| April 20, 2026 | 1.789 |
| April 17, 2026 | 1.789 |
| April 16, 2026 | 1.789 |
| April 15, 2026 | 1.789 |
| April 14, 2026 | 1.789 |
| April 13, 2026 | 1.789 |
| April 10, 2026 | 1.789 |
| April 09, 2026 | 1.789 |
| April 08, 2026 | 1.789 |
| April 07, 2026 | 1.789 |
| April 06, 2026 | 1.789 |
| April 02, 2026 | 1.789 |
| April 01, 2026 | 1.789 |
| March 31, 2026 | 1.789 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Interpace Biosciences, Inc. | 2.116 |
| Medical Marijuana, Inc. | 0.0484 |
| DiaSorin SpA | 6.587 |
| Akso Health Group | 0.2253 |
| Acro Biomedical Co. Ltd. | -- |
Price to Book Value Related Metrics
| PE Ratio | 34.29 |
| PS Ratio | 0.9826 |
| Price to Free Cash Flow | 7.767 |
| Price | 12.01 |
| Earnings Yield | 2.92% |
| Market Cap | 2.642B |
| Operating PE Ratio | 11.20 |
| Normalized PE Ratio | 29.52 |